The prognostic value of the antiperinuclear factor, anti-citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis.

Cornelia H.M. van Jaarsveld, E J ter Borg, Johannes W G Jacobs, +6

PubMed

Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial

Cornelia H.M. van Jaarsveld, Johannes W G Jacobs, M. J. Van Der Veen, +11

Annals of the Rheumatic Diseases

Long-term outcome is better when a methotrexate-based treatment strategy is combined with 10 mg prednisone daily: follow-up after the second Computer-Assisted Management in Early Rheumatoid Arthritis trial

M. Safy, JWG Jacobs, ND IJff, +3

Annals of the Rheumatic Diseases

Responsiveness of four patient-reported outcome measures to assess physical function in patients with knee osteoarthritis

E. Mahler, Nienke Cuperus, JWJ Bijlsma, +4

Scandinavian Journal of Rheumatology

Radiographic features of knee and hip osteoarthritis represent characteristics of an individual, in addition to severity of osteoarthritis

MB Kinds, KL Vincken, EP Vignon, +5

Scandinavian Journal of Rheumatology

Association between serum levels of the proinflammatory protein S100A8/A9 and clinical and structural characteristics of patients with established knee, hip, and hand osteoarthritis

E. Mahler, M.C. Zweers, PL van Lent, +8

Scandinavian Journal of Rheumatology

Post-approval trials of new medicines: widening use or deepening knowledge? Analysis of 10 years of etanercept

JCF van Luijn, Marjorie Danz, JWJ Bijlsma, +2

Scandinavian Journal of Rheumatology

Proteomics to predict the response to tumour necrosis factor-α inhibitors in rheumatoid arthritis using a supervised cluster-analysis based protein score

BVJ Cuppen, Ruth Fritsch‐Stork, Iris Eekhout, +7

Scandinavian Journal of Rheumatology